Idiopathic multicentric Castleman disease (iMCD)

If left untreated, iMCD can severely impact your health

Fight Back With SYLVANT
man-lymph-wall

Idiopathic multicentric Castleman disease (iMCD)

SYLVANT® (siltuximab) is the only FDA-approved treatment for iMCD

Learn More
campaign-woman-lymph-wall-2
mail-icon@2x

Insights on iMCD

Tips and tools delivered straight to your inbox

Sign Up
tips

Understanding
iMCD

Learn More

How SYLVANT
Can Help

Learn More

Uncovering
a Mystery:
Castleman Disease

Watch Videos

Patient
Connect

Learn More

Doctor
Discussion
Guide

Visit Now

Abbreviations: FDA, US Food and Drug Administration; iMCD, idiopathic multicentric Castleman disease.